Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy
Published in Clinical Cancer Research, 2016
Targeting Chronic Lymphocytic Leukemia with an Anti-CD20 Antibody and a Brutons Tyrosine Kinase (BTK) Inhibitor
Download here